FDA/CDC
FDA/CDC
Just under three million will get COVID-19 vaccine in first week
Theoretically, states have already formulated plans for distribution based on the revised lower amount.
FDA/CDC
FDA panel overwhelmingly backs emergency authorization for Pfizer COVID vaccine
“I can assure you that no vaccine will be authorized for use in the United States until FDA career officials feel confident in allowing their own...
FDA/CDC
CDC shortens COVID-19 quarantine time to 10 or 7 days, with conditions
The residual risk is approximately 1%, with an upper limit of 10%, when people quarantine for 10 days. .
FDA/CDC
ACIP: Health workers, long-term care residents first tier for COVID-19 vaccine
State health departments are expected to rely on the recommendation, but ultimately can make their own decisions on how to allocate vaccine in...
FDA/CDC
Moderna filing for FDA emergency COVID-19 vaccine approval, reports 94.1% efficacy
Vaccine efficacy remained consistent across different groups analyzed by age, race/ethnicity, and gender.
FDA/CDC
CDC panel delves into priorities for COVID vaccine distribution
FDA/CDC
FDA authorizes baricitinib combo for COVID-19
FDA/CDC
FDA approves first at-home COVID-19 test kit
The Lucira COVID-19 All-In-One Test-Kit is a single-use test that has a nasal swab to collect samples for people ages 14 and older.
FDA/CDC
Nearly 10% of hospitalized patients with COVID-19 later readmitted
FDA/CDC
FDA grants emergency use authorization to Lilly’s antibody COVID-19 therapy
“We have supplies to distribute now. Product distribution will begin this week.”
FDA/CDC
FDA clears smartphone app to interrupt PTSD-related nightmares
NightWare was tested in a 30-day randomized, sham-controlled trial of 70 patients.